Celyad Oncology SA (CYAD) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.50K	3.50K	-	-
Cost of goods sold	-	-	2.00K	2.00K
Cost of revenue	-	-	2.00K	2.00K
Research and development expenses	669.00K	669.00K	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.05M	1.05M	190.00K	190.00K
Operating expense	-1.06M	-1.06M	597.00K	597.00K
Total operating expenses	-1.06M	-1.06M	599.00K	599.00K
Operating income	1.06M	1.06M	-599.00K	-599.00K
Other non operating income	1.00K	1.00K	500.00	500.00
EBT including unusual items	2.25M	2.25M	-605.00K	-605.00K
EBT excluding unusual items	1.05M	1.05M	-605.00K	-605.00K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-2.78M	-2.78M	385.50K	385.50K
Net income	2.25M	2.25M	-605.00K	-605.00K
Net profit margin	64,357.14%	64,357.14%	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	1.00K	1.00K
Interest expense	-16.00K	-16.00K	-7.50K	-7.50K
Net interest expenses	-16.00K	-16.00K	-6.50K	-6.50K
Depreciation and amortization charges	-	-	21.50K	21.50K
EBITDA	1.10M	1.07M	-577.50K	-577.50K
Gain or loss from assets sale	-1.15M	-1.15M	-115.50K	-115.50K

Ask anything